REQUEST A DEMO
Total
USD $0.00
Search more companies

Northern Luzon Drug Corporation (Philippines)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers | Pharmacies and Drug Stores
Full name: Northern Luzon Drug Corporation Profile Updated: March 31, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English Download a sample report

Northern Luzon Drug Corporation is based in Philippines, with the head office in Quezon City. The enterprise currently operates in the Drugs and Druggists' Sundries Merchant Wholesalers sector. Northern Luzon Drug Corporation was incorporated on September 17, 1997. Northern Luzon Drug Corporation currently employs 958 (2024) people.

Headquarters
Ground Floor Mercury Drug Corporation Compound
Quezon City; National Capital Region; Postal Code: 1100

Contact Details: Purchase the Northern Luzon Drug Corporation report to view the information.

Basic Information
Total Employees:
Purchase the Northern Luzon Drug Corporation report to view the information.
Financial Auditors:
Purchase the Northern Luzon Drug Corporation report to view the information.
Incorporation Date:
September 17, 1997
Key Executives
Purchase this report to view the information.
Chairman and Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Ownership Details
Purchase this report to view the information.
Company Performance
Financial values in the chart are available after Northern Luzon Drug Corporation report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency PHP. Absolute financial data is included in the purchased report.
Total Operating Revenue
1.06%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?